MSB Trading - 2020, page-15476

https://cdn-api.markitdigital.com/apiman-gateway/CommSec/commsec-node-api/1.0/event/document/1410-02183469-3B98D8OBVV0IOF3BPKK456HRTQ/pdf?access_token=Lmh8zocKKbMyzTJbjkfMVBqOskNu

further Sepsis research for you.

Sepsis is also known as blood poisoning, septicaemia, or in its most severe form, septic shock
• It affects ~30 million people worldwide each year, leading to up to 6 million deaths
• Caused by an over-reaction of the immune system to infection, triggering changes that can damage multiple organs
• Initial symptoms are vague and not easily distinguished from less serious conditions
• Diagnosed based on mental status, blood pressure and breathing rate, in addition to presence of an infection.

• Sepsis is the most common cause of death in hospital Intensive Care Units
• Implicated in 1 in 20 deaths in the population as a whole and up to 50% of all hospital deaths
• Approximately 30% of patients diagnosed with severe sepsis do not survive1
• Sepsis has been identified as the most expensive in-patient cost in US hospitals2, costing US$27 billion each year1
• Market opportunity for sepsis/septic shock across the 7 major pharmaceutical markets (US, France, Germany, Italy, Spain, UK and Japan) is estimated to reach US$5.9 billion by 2026

Very Covid 19 relevant.